Kjellson Nina S

DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Nov 1, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.3M
Net Open-Market Flow
-$2.3M
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 1, 2024Sell(S)604$17.16$10K3.8M
Nov 1, 2024Sell(S)73$17.16$1K459K
Nov 1, 2024Sell(S)24K$16.54$396K3.8M
Nov 1, 2024Sell(S)3K$16.54$48K459K
Oct 31, 2024Sell(S)11K$16.46$177K461K
Oct 31, 2024Sell(S)89K$16.46$1.5M3.8M
Oct 30, 2024Sell(S)10K$16.17$160K3.9M
Oct 30, 2024Sell(S)1K$16.17$19K472K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-120198) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about TYRA insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000950170-24-120198"
Ask your agent
Use Arkolith to summarize insider buying and selling at Tyra Biosciences, Inc.
over the last 90 days and cite the filings.